Builds on recent 1-Level PMA Approval SUNNYVALE, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Simplify Medical, Inc., maker of the Simplify® Cervical Artificial Disc, announced today the completion of the Pre-Market Approval...
DUBLIN, Oct. 28, 2020 /PRNewswire/ -- The "Global Sports Medicine Market by Product (Body Reconstruction, Body Support & Recovery), Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries), End User (Hospitals, Physiotherapy Centers...
AUDUBON, Pa., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2020. Worldwide...
Spine company stands the test of time and looks to a year of continued growth October 28, 2020- Noblesville, IN- Nexxt Spine, LLC a leading manufacturer of spinal solutions celebrates 11...
- The Patient Access Program has been developed and will be administered in conjunction with MCRA, a leading healthcare industry advisory firm - The program will expand reimbursement support for two-level...
Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Transmedic Group, a...
JACKSON, Miss., Oct. 27, 2020 /PRNewswire/ -- Zavation Medical Products ("Zavation" or the "Company"), an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS,...
Acquisition Delivers on Commitment to the Promise of Digital Surgery to Improve Patient Outcomes DEERFIELD, Ill., Oct. 23, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine...
TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery,...
October 26, 2020 04:15 PM Eastern Daylight Time CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the closing of its previously announced public offering of 18,750,000 shares of its common...